| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/20/2006 | US20060160824 Indole derivatives as serotonin reuptake inhibitors |
| 07/20/2006 | US20060160819 Substitued piperazine carbamates |
| 07/20/2006 | US20060160813 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis |
| 07/20/2006 | US20060160808 New carboxylic acid derivatives, their preparation and their use |
| 07/20/2006 | US20060160801 Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160794 Such as [1-(3,5-bis-trifluoromethylbenzyl)-5-imidazol-1-yl-1H-[1,2,3]triazol-4-yl]-[5-(2-chlorophenyl)-3-hydroxymethyl-isoxazol-4-yl]-methanone; for treatment of depression, anxiety, irritable bowel syndrome, and emesis |
| 07/20/2006 | US20060159929 Epoxy compound and cured epoxy resin product |
| 07/20/2006 | US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy |
| 07/20/2006 | CA2594871A1 Exo- and diastereo- selective syntheses of himbacine analogs |
| 07/20/2006 | CA2594807A1 An exo-selective synthesis of himbacine analogs |
| 07/20/2006 | CA2594741A1 Synthesis of himbacine analogs |
| 07/20/2006 | CA2594377A1 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists |
| 07/20/2006 | CA2593450A1 Indole derivatives for treating viral infections |
| 07/20/2006 | CA2592723A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/19/2006 | EP1680415A1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 07/19/2006 | EP1680406A1 N-substituted benzene sulfonamides |
| 07/19/2006 | EP1680401A2 Indolinone derivatives and their use in treating disease-states such as cancer |
| 07/19/2006 | EP1680114A2 Triazole compounds and uses related thereto |
| 07/19/2006 | EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/19/2006 | EP1395575B1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1299361B1 Pyrazole derivatives |
| 07/19/2006 | CN1805955A Oxime ester compound and photopolymerization initiator containing such compound |
| 07/19/2006 | CN1805954A Indole derivatives as serotonin reuptake inhibitors |
| 07/19/2006 | CN1805953A Indole derivatives as serotonin reuptake inhibitors |
| 07/19/2006 | CN1805943A Alpha substituted carboxylic acid as PPAR modulators |
| 07/19/2006 | CN1805940A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 07/19/2006 | CN1805929A Phosphodiesterase 4 inhibitors |
| 07/19/2006 | CN1805747A 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 07/19/2006 | CN1803797A Inhibitors of dipeptidyl peptidase IV |
| 07/19/2006 | CN1803795A Substituted piperidine compounds for use as h3 histamine receptor antagonists |
| 07/19/2006 | CN1264839C Non-nucleoside reverse transcriptase inhibitors |
| 07/19/2006 | CN1264838C Indole derivatives for treating central nervous system disease |
| 07/19/2006 | CN1264833C Nonviscous protein type synthetic compound or its carrier combined compound |
| 07/19/2006 | CN1264824C Quinazoline derivatives |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | US7078542 pi-electron donor group bonded to a pi-electron conjugated bridge group bonded to a mono- or dicyanodihydrofuran acceptor; large hyperpolarizability, dipole moment, and electrooptic coefficients; electrooptics |
| 07/18/2006 | US7078526 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 07/18/2006 | US7078430 3-carbamoyl-pyran that is n-derivatized by dihydroxyheptanoic acid or 6-ethyl-4-hydroxy-pyran-2-one; anticholesterol agents |
| 07/18/2006 | US7078424 Central nervous system disorders; alopecia |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078418 e.g., 2,6-bis(1-aziridino-1-hydroxyiminomethyl)pyridine; treating colon, stomach, lung, breast and uterus cancer |
| 07/18/2006 | US7078417 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 07/18/2006 | US7078401 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 07/18/2006 | US7078399 Antiulcer agents; antiinflammatory agents; therapy for ear infections |
| 07/18/2006 | CA2364864C New metalloprotease inhibitors, the procedure for preparing them and the pharmaceutical compounds containing them |
| 07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/18/2006 | CA2341890C Oxygen-containing heterocyclic compounds |
| 07/18/2006 | CA2309771C New substitute dimeric derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 07/18/2006 | CA2242425C Quinazoline derivatives as vegf inhibitors |
| 07/13/2006 | WO2006074025A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 07/13/2006 | WO2006073967A1 Piperidine derivatives as prodrugs of potassium channel inhibitors |
| 07/13/2006 | WO2006073367A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators |
| 07/13/2006 | WO2006072736A1 N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands |
| 07/13/2006 | WO2006072430A1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists |
| 07/13/2006 | WO2006072370A1 Selected benzofuran derivatives |
| 07/13/2006 | WO2006072353A1 Azetidine-substituted pyrazolines as par-1 antagonists |
| 07/13/2006 | WO2006072351A1 Heteroaryl-substituited pyrazolines as par-1 antagonists |
| 07/13/2006 | WO2006039718A3 Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors |
| 07/13/2006 | WO2004065367A8 Viral polymerase inhibitors |
| 07/13/2006 | US20060154969 Adenosine receptor selective modulators |
| 07/13/2006 | US20060154967 e.g. [2-methyl-5-trifluoromethyl-2H-1,2,3-triazole-4-carboxylic acid methyl ester; fungicide; against the phytopathogenic fungi: Fungi imperfecti (Botrytis, Pyricularia, Helminthosporium), Basidiomycetes (Rhizoctonia, Hemileia), Ascomycetes classes (Venturia, Erysiphe), Oomycetes classes (Phytophthora) |
| 07/13/2006 | US20060154964 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/13/2006 | US20060154949 Arylindenopyridines and related therapeutic and prophylactic methods |
| 07/13/2006 | US20060154943 Trimethoprim derivative; 5-[6,7-Dimethoxy-2-(7-methoxy-1H-indol-3-ylmethyl)-benzofuran-4-ylmethyl]-pyrimidine-2,4-diamine; potent activity against dihydrofolate reductase, mutated enzyme; superior bioavailability, antibacterial activity; gram positive and negative pathogens |
| 07/13/2006 | US20060154942 Quinazolinone derivatives useful as anti-hyperalgesic agents |
| 07/13/2006 | US20060154913 Drugs for treatment of respiratory syncytial virus and salt formation |
| 07/13/2006 | US20060154912 Isophtalic acid derivatives |
| 07/13/2006 | US20060154876 Serum cholesterol lowering agent or preventive or therapeutic agent for atherosclerosis |
| 07/13/2006 | US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 07/13/2006 | US20060153931 Prevention of flap necrosis in plastic surgery |
| 07/13/2006 | DE102004063797A1 Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide Oxygen-containing fused phenylpiperazine and Phenyldiazepancarboxamide |
| 07/13/2006 | CA2596393A1 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions |
| 07/13/2006 | CA2594418A1 N-(heteroaryl)-1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands |
| 07/13/2006 | CA2594091A1 Selected benzofuran derivatives |
| 07/13/2006 | CA2593266A1 Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| 07/13/2006 | CA2593098A1 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 07/13/2006 | CA2587195A1 Cycloalkyl keto piperidine tachykinin receptor antagonists |
| 07/13/2006 | CA2576332A1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists |
| 07/12/2006 | EP1679313A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 07/12/2006 | EP1679310A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 07/12/2006 | EP1678167A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 07/12/2006 | EP1678166A2 Protein kinase inhibitors |
| 07/12/2006 | EP1678165A2 Method for the production of amino crotonyl compounds |
| 07/12/2006 | EP1678162A1 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 07/12/2006 | EP1678160A1 Pyrazine derivatives and pharmaceutical use thereof |
| 07/12/2006 | EP1678147A1 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |
| 07/12/2006 | EP1678145A2 Benzimidazoles useful as modulators of ion channels |
| 07/12/2006 | EP1678144A1 1,5,7-TRISUBSTITUTED BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABA-a RECEPTOR COMPLEX |
| 07/12/2006 | EP1678138A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv |
| 07/12/2006 | EP1678137A1 Compositions and methods for viral inhibition |
| 07/12/2006 | EP1678121A2 Tao kinase modulators and methods of use |
| 07/12/2006 | EP1677785A1 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors |
| 07/12/2006 | EP1677782A2 Inhibitors of cathepsin s |
| 07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
| 07/12/2006 | EP1394156B1 Chromene compound |
| 07/12/2006 | EP1303499B1 Tetrazole derivatives |
| 07/12/2006 | EP1103547B1 Formazan metal complex |
| 07/12/2006 | CN1802369A Cgrp受体拮抗剂 Cgrp receptor antagonists |